drugset
drugset / Trial / NCT00977197

A Placebo-Controlled Trial of Pregabalin (Lyrica) for Irritable Bowel Syndrome

NCT00977197 ↗

Phase 2 Completed 85 enrolled Mayo Clinic Pfizer · collab
RandomizedParallel-groupTriple-blindTreatment

Summary

This study is being done to see if Lyrica helps people with irritable bowel syndrome.

Timeline

Start
2010-03
Primary completion
2015-06
Completion
2015-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pregabalin Small molecule 225 mg —

Indications

irritable bowel syndrome